Patent US4032631A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4032631A Expired / Lapsed US ⏱️ 0.0 years remaining

Mixture of antibiotics produced by new species of micromonospora

Assignee: Pfizer Inc
•
Filing: 1975-12-19
•
Granted: 1977-06-28
•
Expires: 1995-12-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A new species of Micromonospora, designated Micromonospora saitamica sp. nov. Routien, when subjected to submerged aerobic fermentation, produces at least four antibiotics. One of these is previously reported rubradirin produced by Streptomyces achromogenes var. rubradiris NRRL 3061.

Inventors

  • 👤 Walter D. Celmer
  • 👤 Walter P. Cullen
  • 👤 Charles E. Moppett
  • 👤 John R. Oscarson
  • 👤 John B. Routien
  • 👤 Riichiro Shibakawa
  • 👤 Junsuke Tone

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 05:35
CPC Classifications
C; C07; C07G; C07G11/00; A; A61; A61K; A61K35/00; A61K35/66; A61K35/74; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/863; Y10S435/886

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 113 words
Antibiotic substance Compound 42,752 which is soluble in chloroform, methylisobutyl ketone, dimethylsulfoxide and dimethylformamide; moderately soluble in methanol and ethanol; and insoluble in hexane, heptane and water; has absorption maxima in dioxane in the ultraviolet light region of the spectrum at 264, 324 and 500 mμ with E 1cm 1% values of 345 , 265 and 20, respectively; has the average composition by weight of 61.11% carbon, 5.58% hydrogen, 3.81% nitrogen and 29.50% oxygen (by difference); and when pelleted in KBr exhibits characteristic absorption in the infrared region at the following wavelengths in microns: 3.00, 3.42, 5.82, 6.00, 6.14, 6.20, 6.37, 6.62, 7.25, 7.58, 7.82, 8.92, 9.22, 9.75, 10.00, 10.75, 11.55 and 13.65.
Claim 2
Dependent Claim 113 words
Antibiotic substance Compound 42,752 which is soluble in chloroform, methylisobutyl ketone, dimethylsulfoxide and dimethylformamide; moderately soluble in methanol and ethanol; and insoluble in hexane, heptane and water; has absorption maxima in dioxane in the ultraviolet light region of the spectrum at 264, 324 and 500 mμ with E 1cm 1% values of 345 , 265 and 20, respectively; has the average composition by weight of 61.11% carbon, 5.58% hydrogen, 3.81% nitrogen and 29.50% oxygen (by difference); and when pelleted in KBr exhibits characteristic absorption in the infrared region at the following wavelengths in microns: 3.00, 3.42, 5.82, 6.00, 6.14, 6.20, 6.37, 6.62, 7.25, 7.58, 7.82, 8.92, 9.22, 9.75, 10.00, 10.75, 11.55 and 13.65.
Claim 3
Dependent Claim 113 words
Antibiotic substance Compound 43,038 which is soluble in chloroform, methylisobutyl ketone, dimethylsulfoxide and dimethylformamide; moderately soluble in methanol and ethanol; and insoluble in hexane, heptane and water; has absorption maxima in dioxane in the ultraviolet light region of the spectrum at 265, 339 and 510 mμ with E 1 cm 1% values of 267, 278 and 15, respectively; has the average composition by weight of 59.13% carbon, 4.80% hydrogen, 4.61% nitrogen and 31.46% oxygen (by difference); and when pelleted in KBr exhibits characteristic absorption in the infrared region at the following wavelengths in microns: 2.96, 3.40, 5.77, 5.98, 6.08, 6.19, 6.35, 6.50, 6.86, 7.25, 7.55, 7.78, 8.03, 8.35, 8.60, 8.90, 9.95 and 13.64.
Claim 4
Dependent Claim 113 words
Antibiotic substance Compound 43,038 which is soluble in chloroform, methylisobutyl ketone, dimethylsulfoxide and dimethylformamide; moderately soluble in methanol and ethanol; and insoluble in hexane, heptane and water; has absorption maxima in dioxane in the ultraviolet light region of the spectrum at 265, 339 and 510 mμ with E 1 cm 1% values of 267, 278 and 15, respectively; has the average composition by weight of 59.13% carbon, 4.80% hydrogen, 4.61% nitrogen and 31.46% oxygen (by difference); and when pelleted in KBr exhibits characteristic absorption in the infrared region at the following wavelengths in microns: 2.96, 3.40, 5.77, 5.98, 6.08, 6.19, 6.35, 6.50, 6.86, 7.25, 7.55, 7.78, 8.03, 8.35, 8.60, 8.90, 9.95 and 13.64.
Claim 5
Dependent Claim 113 words
Antibiotic substance Compound 43,139 which is soluble in chloroform, methylisobutyl ketone, dimethylsulfoxide and dimethylformamide; moderately soluble in methanol and ethanol; and insoluble in hexane, heptane and water; has absorption maxima in dioxane in the ultraviolet light region at 295, 308, 345 and 500 mμ with E 1 cm 1% values of 222, 227, 214 and 15, respectively; has the average composition by weight of 60.39% carbon, 5.68% hydrogen, 4.07% nitrogen and 29.86% oxygen (by difference); and when pelleted in KBr exhibits characteristic absorption in the infrared region at the following wavelengths in microns: 2.97, 3.40, 5.77, 6.00, 6.08, 6.19, 6.50, 6.85, 7.25, 7.55, 8.04, 8.60, 8.95, 9.25, 9.92, 10.16, 11.55, 13.20 and 13.64.
Claim 6
Dependent Claim 113 words
Antibiotic substance Compound 43,139 which is soluble in chloroform, methylisobutyl ketone, dimethylsulfoxide and dimethylformamide; moderately soluble in methanol and ethanol; and insoluble in hexane, heptane and water; has absorption maxima in dioxane in the ultraviolet light region at 295, 308, 345 and 500 mμ with E 1 cm 1% values of 222, 227, 214 and 15, respectively; has the average composition by weight of 60.39% carbon, 5.68% hydrogen, 4.07% nitrogen and 29.86% oxygen (by difference); and when pelleted in KBr exhibits characteristic absorption in the infrared region at the following wavelengths in microns: 2.97, 3.40, 5.77, 6.00, 6.08, 6.19, 6.50, 6.85, 7.25, 7.55, 8.04, 8.60, 8.95, 9.25, 9.92, 10.16, 11.55, 13.20 and 13.64.
Claim 7
Dependent Claim 42 words
An antibiotic complex produced by cultivating Micromonospora saitamica sp. nov. Routien ATCC 31178 under submerged aerobic conditions in an aqueous nutrient medium containing an assimilable source of carbon and nitrogen until substantial antibiotic activity is obtained and separation said antibiotic complex therefrom.
Claim 8
Dependent Claim 42 words
An antibiotic complex produced by cultivating Micromonospora saitamica sp. nov. Routien ATCC 31178 under submerged aerobic conditions in an aqueous nutrient medium containing an assimilable source of carbon and nitrogen until substantial antibiotic activity is obtained and separation said antibiotic complex therefrom.

References Cited (Backward Citations)

US3335057A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-06-27 1980-12-27 1981-06-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-06-27 1984-12-27 1985-06-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-06-27 1988-12-27 1989-06-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag